mTOR Inhibitor - Globe Thesis

Keyword [mTOR Inhibitor] Result: 41 - 60 \| Page: 3 of 3
41.	Preliminary Study On The Efficacy And Mechanism Of Rapamycin Target Protein (mTOR) Inhibitor TAC In The Treatment Of Cystic Echinococcosis In Mice
42.	CRISPR/Cas9 Screening And Identification Of New Everolimus Resistance Target MAGIX In Renal Cell Carcinoma
43.	Radio Sensitizing Effect Of Double PI3K/mTOR Inhibitor NVPBEZ235 On Hela Cells Of Cervical Cancer
44.	Efficacy And Safety Of Molecular Targeted Drugs Combined With Endocrine Drugs In The Treatment Of Breast Cancer:A Meta-analysis
45.	Clinical Efficacy And Reconstruction Effects Of The Immune Tolerance Of Treg Cells Of Low-dose Rapamycin In Patients With Active Rheumatoid Arthritis
46.	Design,Synthesis,and Antitumor Evaluation Of Novel Dual Pan-PI3K/mTOR Inhibitors
47.	The Antiproliferative Effect And Mechanism Of Cardamonin On MTOR Inhibitor Resistant Tumor Cells
48.	LncRNA Mediates The Role Of Autophagy In Uveal Melanoma
49.	Mechanism Of MTOR Inhibitor Regulating Drug Sensitivity Of Pancreatic Cancer
50.	Evaluation Of Anti-tumor Activity Of Dual PI3K-mTOR Inhibitor And Preliminary Study Of Its Mechanism
51.	A Meta-analysisi Of The Efficacy And Safety Of PI3K/AKT/mTOR Inhibitors Combined Wiht Endocrine Therapy On Advanced Breast Cancer
52.	Characterization of BK viral responses to the dual-PI3K/mTOR inhibitor dactolisib (NVP BEZ-235) in a renal cell culture model
53.	The Role And Related Mechanism Of Androgen In Left Ventricular Hypertrophy In Postmenopausal Hypertension Via MTOR/ P70S6K1/4EBP1 Pathway
54.	MTOR Inhibition Overcomes Primary And Acquired Resistance To Wee1 Inhibition By Augmenting Replication Stress In Epithelial Ovarian Cancers
55.	Experimental Study Of MTOR Inhibitor Delaying The Progression Of Chronic Aristolochic Acid Nephropathy
56.	Immune-regulatory Effect Of Novel MTOR Inhibitor AZD8055 And Its Corresponding Mechanism
57.	Clinical Study Of RMT Regimen In The Treatment Of PCNSL And Clinical And In Vitro Study Of MTOR Inhibitor RAD001 Combined With Gemcitabine In PTCL
58.	Anti-tumor Activity And Preliminary Safety Evaluation Of Dual PI3K-mTOR Inhibitor And Preliminary Studies On The Mechanism Of Its Inducing Cell Death
59.	HDAC6 Inhibitor Strengthens The Anti-proliferative Activity Of PI3K/mTOR Inhibitor BEZ235 Bysuppressing Up-regulation Of RTKs In Breast Cancer
60.	Analysis Of The Resistance Mechanism Of Breast Cancer Cells To Palbociclib And The Study Of The Anti-breast Cancer Effect Of Novel MTOR Inhibitor FP-208 In Cooperation With Palbociclib
<<First <Prev Next> Last>> Jump to